After 12 weeks of nebulized NAC, patients’ mean phlegm scores, as measured by the COPD assessment test, significantly decreased from 3.47 at baseline to 2.62. N-acetylcysteine (NAC) nebulizer ...

In COPD and BPD models ... the company will cement its position at the leading-edge of inhaled live biotherapeutic drug development and start addressing major unmet medical needs by decreasing ...

糖皮质激素（GC）的药理作用及临床适应症广泛，因其强大的抗炎、平喘作用，在呼吸科常被用于 慢性阻塞性肺疾病 （ COPD ）、 哮喘 等疾病治疗。GC 可缓解患者的临床症状、改善肺功能，提高生活质量。

The NE-U22V MicroAir®, the world’s smallest nebulizer utilizing Vibrating Mesh Technology (V.M.T.), efficiently delivers solution medications for patients suffering from asthma, COPD or other ...

COPD - Chronic Obstructive Pulmonary Disease ... The study involved the comparison of the treatment of 231 patients with similar background and disease conditions over two separate six-month ...

The disease can be caused by long-term exposure to inhaled irritants, which is why it’s prevalent in smokers. But non-smokers can also develop COPD. Standard treatment includes drugs and drug ...

Current treatment options for COPD include bronchodilators such as beta2-agonists and anticholinergics, standalone or combination inhaled corticosteroids (ICS), and other combination medications.

Healthcare decision-makers are facing significant challenges that will intensify in the coming years as they work to address ...

At the moment, the recommended treatment for COPD in Europe is an inhaled corticosteroid (ICS), a long-acting beta-agonist (LABA) and long-acting muscarinic antagonist (LAMA), or LABA/LAMA dual ...

The Global Initiative for Chronic Obstructive Lung Disease, or GOLD, is the world’s preeminent COPD research and advocacy organization. Founded in 1997 in collaboration with the U.S. National ...

According to Research by SNS Insider, Nebulizer Market Growth is Driven by Rising Prevalence of Chronic Respiratory Diseases and Technological Advancements.Austin, Oct. 18, 2024 (GLOBE NEWSWIRE) -- ...

These figures indicate the enormous scope for nebulizers in the treatment of chronic respiratory conditions such as COPD, asthma, and cystic fibrosis, considering the increasing population.